Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Revision of Prior Period, Accounting Standards Update, Adjustment	[1]	Common Stock	Paid-In Capital	Retained Earnings	Retained Earnings Revision of Prior Period, Accounting Standards Update, Adjustment	[1]	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2021				13,673,898
Balance at beginning of period at Dec. 31, 2021	$ 217,707			$ 13,674	$ 111,021	$ 99,189			$ (6,177)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(31,027)								(31,027)
Dividends on common shares	(1,477)					(1,477)
Issuance of common stock (in shares)				3,848,485
Issuance of common stock	59,468			$ 3,848	55,620
Issuance of restricted stock, net of forfeitures (in shares)				63,950
Issuance of restricted stock, net of forfeitures	0			$ 64	(64)
Stock-based compensation expense	282				282
Net income	5,324					5,324
Balance at end of period (in shares) at Mar. 31, 2022				17,586,333
Balance at end of period at Mar. 31, 2022	$ 250,277			$ 17,586	166,859	103,036			(37,204)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Balance at beginning of period (in shares) at Dec. 31, 2021				13,673,898
Balance at beginning of period at Dec. 31, 2021	$ 217,707			$ 13,674	111,021	99,189			(6,177)
Balance at end of period (in shares) at Dec. 31, 2022				17,598,123
Balance at end of period at Dec. 31, 2022	230,268	$ (1,198)		$ 17,598	167,537	111,573	$ (1,198)		(66,440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	6,216								6,216
Dividends on common shares	(1,933)					(1,933)
Tax withholding related to vesting of restricted stock (in shares)				(5,790)
Tax withholding related to vesting of restricted stock	(73)			$ (6)	(67)
Issuance of restricted stock, net of forfeitures (in shares)				1,546
Issuance of restricted stock, net of forfeitures	0			$ 2	(2)
Stock-based compensation expense	454				454
Net income	5,043					5,043
Balance at end of period (in shares) at Mar. 31, 2023				17,593,879
Balance at end of period at Mar. 31, 2023	$ 238,777			$ 17,594	$ 167,922	$ 113,485			$ (60,224)

[1] (1) Represents the impact of the adoption of Accounting Standards Update ("ASU") No. 2016-13: CECL